Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The Journal of General Virology|May 30, 2020
Update: proposed reference sequences for subtypes of hepatitis E virus (species <i>Orthohepevirus A</i>)Donald B Smith, Jacques Izopet, Florence Nicot, et al.
The Journal of Infection|July 4, 2018
Acute hepatitis E in French patients and neurological manifestationsFlorence Abravanel, Julie Pique, Elisabeth Couturier, et al.
JACC. Advances|June 18, 2025
Simple Renal Cysts in Marfan Syndrome: Prevalence and Association With Aortic EventsClaire Bouleti, Noemie Tence, Raphael Thuillier, et al.
Frontiers in Microbiology|February 15, 2021
Classification of the Zoonotic Hepatitis E Virus Genotype 3 Into Distinct SubgenotypesFlorence Nicot, Chloé Dimeglio, Marion Migueres, et al.
World Journal of Hepatology|October 3, 2014
Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patientsDelphine Bonnet, Matthieu Guivarch, Emilie Bérard, et al.
European Heart Journal. Imaging Methods and Practice|April 13, 2026
New CT-based dural ectasia criteria using machine learning to diagnose Marfan and Loeys-Dietz syndromesClaire Bouleti, Raphael Thuillier, Yoann Moeuf, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2014
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patientsCédric Laouénan, Patrick Marcellin, Martine Lapalus, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin TherapySebastien Lhomme, Nassim Kamar, Florence Nicot, et al.
The Journal of Antimicrobial Chemotherapy|April 18, 2015
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategiesPierre Frange, Lambert Assoumou, Diane Descamps, et al.
The Journal of Antimicrobial Chemotherapy|January 6, 2015
Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patientsSlim Fourati, Charlotte Charpentier, Corinne Amiel, et al.
Pageof 6